StockData
Korro Bio, Inc. logo

Korro Bio, Inc. (KRRO) stock

KRRONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$12.32−0.39 (-3.07%)

Close on Nov 17, 2026Market cap $181.42MP/E –Yield –

Korro Bio total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Korro Bio's total debt was $0 at Sep 30, 2023. For fiscal 2022 it was $10.00M, up 1100.5% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2022Dec 31, 2022$10.00M+1100.5%
FY2021Dec 31, 2021$833.00K+362.8%
FY2019Dec 31, 2019$180.00K-48.4%
FY2018Dec 31, 2018$349.00K–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2023Sep 30, 2023$0-100.0%
Q2 FY2023Jun 30, 2023$0-100.0%
Q1 FY2023Mar 31, 2023$11.67M+250.0%
Q4 FY2022Dec 31, 2022$10.00M+1100.5%
Q3 FY2022Sep 30, 2022$8.33M+4529.4%
Q2 FY2022Jun 30, 2022$5.83M+2527.5%
Q1 FY2022Mar 31, 2022$3.33M+855.0%
Q4 FY2021Dec 31, 2021$833.00K–
Q4 FY2019Dec 31, 2019$180.00K–
Q3 FY2019Sep 30, 2019$222.00K–
Q4 FY2018Dec 31, 2018$349.00K–

More Korro Bio figures

See a number that looks wrong?